Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?
- PMID: 26940926
- DOI: 10.1016/j.jacc.2015.12.030
Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?
Keywords: arrhythmia; mutation; sodium-channel blocker; sudden cardiac death.
Comment on
-
Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.J Am Coll Cardiol. 2016 Mar 8;67(9):1053-1058. doi: 10.1016/j.jacc.2015.12.033. J Am Coll Cardiol. 2016. PMID: 26940925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
